Kalaris Therapeutics, Inc. reported improved Q3'25 results, with a net loss of $11.9M and $77M in cash. Click here to read why KLRS stock is a Buy.

Philosophy is the quiet engine behind everything we think, question, and imagine. From Athens to Kyoto, from Königsberg to Calcutta, the world’s greatest thinkers have tried to make sense of existence ...

Over 1.5 million people globally experience gradual vision loss due to retinitis pigmentosa (RP). This condition comprises a group of inherited eye disorders characterized by the degeneration of cells ...

The best-selling author's supernatural universe spans books, TV, film, comics, and more. Rice, who died in 2021, kicked off her world of bloodsuckers, spellcasters, and restless spirits with her 1976 ...